| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Tadalafil | FAERS: 10 | US FAERS | |
| 2 | Sildenafil Citrate | FAERS: 8 | US FAERS | |
| 3 | Dimethyl Fumarate | FAERS: 2 | US FAERS | |
| 4 | Temozolomide | FAERS: 2 | US FAERS | |
| 5 | Vemurafenib | FAERS: 2 | US FAERS | |
| 6 | Azathioprine | FAERS: 1 | US FAERS | |
| 7 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 8 | Glatiramer Acetate | FAERS: 1 | US FAERS | |
| 9 | Raloxifene Hydrochloride | FAERS: 1 | US FAERS | |
| 10 | Tacrolimus | FAERS: 1 | US FAERS | |
| 11 | Thalidomide | FAERS: 1 | US FAERS | |
| 12 | dabrafenib | FAERS: 1 | US FAERS | |
| 13 | trametinib | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.